Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00160563
Status:
TERMINATED
Last Update Posted:
2015-03-03
First Post:
2005-09-08
Brief Title:
Prevention of Asthma With Levocetirizine 36 Month Treatment in Young Children Suffering From Eczema Atopic Dermatitis and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial NCT00152464
Sponsor:
UCB Pharma
Organization:
UCB Pharma
Organization Data
Organization:
UCB Pharma
Class:
INDUSTRY
Study ID:
A00384
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UCB Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None